Development of Hybrid Flow Diverting Stent

Our primary mandate at API is to advance basic research and innovation to commercialization by providing access to world-class industry expertise, services, and infrastructure. Our activities focuses on engaging and supporting drug discovery and development initiatives, ensuring compliance with regulatory standards and driving innovation and commercialization through collaborative research and clinical studies. The project aims to research the mechanisms of action in how flow diverting brain stents function and also further the development of a first-of-its-kind flow diverting brain stent, made of both polymer and metal components leading to new areas of potential design and development pathways for improved products. The anticipated social and economic benefits come from enhanced patient outcomes from effectively treating brain aneurysms.

Faculty Supervisor:

Michael Kallos

Student:

Partner:

Applied Pharmaceutical Innovation

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services; Retail trade

University:

University of Calgary

Program: